Story · Medicine & Biotech · Mind & Brain

Investigational treatments for lung cancer, Huntington’s disease and Alzheimer's gain Innovation Passports through the Innovative Licensing and Access Pathway

1 outlet · first reported by MHRA (UK) 2d ago

Coverage, in order

  1. 2d ago
    MHRA (UK) UK indie
    Investigational treatments for lung cancer, Huntington’s disease and Alzheimer's gain Innovation Passports through the Innovative Licensing and Access Pathway

    Three innovative medicines with the potential to meet unmet needs in lung cancer, Huntington’s disease and Alzheimer’s disease have been given Innovation Passports, the Medicines and Healthcare products Regulatory Agency (MHRA) announced today.

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.